| The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 KB Tran, JJ Lang, K Compton, R Xu, AR Acheson, HJ Henrikson, ... The Lancet 400 (10352), 563-591, 2022 | 454 | 2022 |
| Antibody–drug conjugates (ADCs) for cancer therapy: Strategies, challenges, and successes M Abdollahpour‐Alitappeh, M Lotfinia, T Gharibi, J Mardaneh, ... Journal of cellular physiology 234 (5), 5628-5642, 2019 | 212 | 2019 |
| Potential drugs used in the antibody–drug conjugate (ADC) architecture for cancer therapy S Yaghoubi, MH Karimi, M Lotfinia, T Gharibi, M Mahi‐Birjand, E Kavi, ... Journal of cellular physiology 235 (1), 31-64, 2020 | 136 | 2020 |
| The biological functions of IL-17 in different clinical expressions of Helicobacter pylori-infection N Bagheri, F Azadegan-Dehkordi, H Shirzad, M Rafieian-Kopaei, ... Microbial pathogenesis 81, 33-38, 2015 | 100 | 2015 |
| Comparative Immune Response in Children and Adults with H. pylori Infection A Razavi, N Bagheri, F Azadegan-Dehkordi, M Shirzad, G Rahimian, ... Journal of immunology research 2015 (1), 315957, 2015 | 99 | 2015 |
| Association between virulence factors of helicobacter pylori and gastric mucosal interleukin-18 mRNA expression in dyspeptic patients N Bagheri, A Taghikhani, G Rahimian, L Salimzadeh, FA Dehkordi, ... Microbial pathogenesis 65, 7-13, 2013 | 94 | 2013 |
| The role of T helper 1-cell response in Helicobacter pylori-infection N Bagheri, L Salimzadeh, H Shirzad Microbial pathogenesis 123, 1-8, 2018 | 88 | 2018 |
| Frequency of virulence factors in Helicobacter pylori-infected patients with gastritis L Salimzadeh, N Bagheri, B Zamanzad, F Azadegan-Dehkordi, ... Microbial pathogenesis 80, 67-72, 2015 | 84 | 2015 |
| Virulence factors of Helicobacter pylori vacA increase markedly gastric mucosal TGF-β1 mRNA expression in gastritis patients G Rahimian, MH Sanei, H Shirzad, F Azadegan-Dehkordi, A Taghikhani, ... Microbial pathogenesis 67, 1-7, 2014 | 82 | 2014 |
| ASSOCIATION OF THE VIRULENCE FACTORS OF HELICOBACTER PYLORI AND GASTRIC MUCOSAL INTERLEUKIN-17/23 MRNA EXPRESSION IN DYSPEPTIC PATIENTS N Bagheri, G Rahimian, L Salimzadeh, F Azadegan, M Rafieian-Kopaei, ... EXCLI JOURNAL 12, 5-14, 2013 | 72 | 2013 |
| Toll‐like receptors (TLRs): An old family of immune receptors with a new face in cancer pathogenesis Y Mokhtari, A Pourbagheri‐Sigaroodi, P Zafari, N Bagheri, SH Ghaffari, ... Journal of Cellular and Molecular Medicine 25 (2), 639-651, 2021 | 65 | 2021 |
| Downregulated regulatory T cell function is associated with increased peptic ulcer in Helicobacter pylori-infection N Bagheri, H Shirzad, S Elahi, F Azadegan-Dehkordi, G Rahimian, ... Microbial pathogenesis 110, 165-175, 2017 | 61 | 2017 |
| Toll‐like receptors (TLRs) in cancer; with an extensive focus on TLR agonists and antagonists A Keshavarz, A Pourbagheri‐Sigaroodi, P Zafari, N Bagheri, SH Ghaffari, ... IUBMB life 73 (1), 10-25, 2021 | 60 | 2021 |
| Up-regulated Th17 cell function is associated with increased peptic ulcer disease in Helicobacter pylori-infection N Bagheri, A Razavi, B Pourgheysari, F Azadegan-Dehkordi, G Rahimian, ... Infection, Genetics and Evolution 60, 117-125, 2018 | 57 | 2018 |
| Inhibition of Th1 and Th17 cells by medicinal plants and their derivatives: a systematic review M Asadi‐Samani, N Bagheri, M Rafieian‐Kopaei, H Shirzad Phytotherapy Research 31 (8), 1128-1139, 2017 | 56 | 2017 |
| Protective effects of pharmacological agents against aminoglycoside-induced nephrotoxicity: A systematic review M Mahi-Birjand, S Yaghoubi, M Abdollahpour-Alitappeh, Z Keshtkaran, ... Expert Opinion on Drug Safety 19 (2), 167-186, 2020 | 55 | 2020 |
| Chimeric antigen receptor based therapy as a potential approach in autoimmune diseases: how close are we to the treatment? M Sadeqi Nezhad, A Seifalian, N Bagheri, S Yaghoubi, MH Karimi, ... Frontiers in immunology 11, 603237, 2020 | 51 | 2020 |
| The contributory role of lymphocyte subsets, pathophysiology of lymphopenia and its implication as prognostic and therapeutic opportunity in COVID-19 M Delshad, N Tavakolinia, A Pourbagheri-Sigaroodi, A Safaroghli-Azar, ... International immunopharmacology 95, 107586, 2021 | 49 | 2021 |
| Role of regulatory T-cells in different clinical expressions of Helicobacter pylori infection N Bagheri, F Azadegan-Dehkordi, G Rahimian, M Rafieian-Kopaei, ... Archives of medical research 47 (4), 245-254, 2016 | 49 | 2016 |
| Serum levels of IL-32 in patients with type 2 diabetes mellitus and its relationship with TNF-α and IL-6 R Fadaei, N Bagheri, E Heidarian, A Nouri, Z Hesari, N Moradi, A Ahmadi, ... Cytokine 125, 154832, 2020 | 48 | 2020 |
Professor Hedayatollah ShirzadShahrekord University of Medical Sciences在 skums.ac.ir 的电子邮件经过验证
